We are live on
!
Find out more
Verrica Pharmaceuticals
VRCA
VRCA
50 hedge funds and large institutions have $29.8M invested in Verrica Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 16 increasing their positions, 12 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
117% more call options, than puts
Call options by funds: $176K | Put options by funds: $81K
33% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 12
10% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 10
2% more funds holding
Funds holding: 49 → 50 (+1)
0.14% more ownership
Funds ownership: 2.49% → 2.63% (+0.14%)
1% less capital invested
Capital invested by funds: $29.9M → $29.8M (-$158K)
Holders
50
Holders Change
+1
Holders Change %
+2.04%
% of All Funds
0.8%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
16
Reduced
12
Closed
10
Calls
$176K
Puts
$81K
Net Calls
+$95K
Net Calls Change
+$146K
Top Buyers
| 1 |
Millennium Management
New York
|
+$351K |
| 2 |
CI
Conning Inc
Hartford,
Connecticut
|
+$344K |
| 3 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$133K |
| 4 |
E
Ergoteles
New York
|
+$94.9K |
| 5 |
Kovitz Investment Group Partners
Chicago,
Illinois
|
+$80.4K |
Top Sellers
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$1.42M |
| 2 |
BlackRock
New York
|
-$519K |
| 3 |
FI
Fosun International
Hong Kong,
China
|
-$409K |
| 4 |
Renaissance Technologies
New York
|
-$197K |
| 5 |
Morgan Stanley
New York
|
-$77.7K |
